About

Dr. Jennifer Bacci is the Endowed Associate Professor of Innovative Pharmacy Practice at the University of Washington School of Pharmacy. Her research focuses on the application of implementation science to evaluate and advance the adoption of innovative patient care models in community pharmacy practice, including childhood and adult vaccinations, point-of-care testing, chronic disease management, pharmacist prescribing, and medical billing. She collaborates closely with community partners to address needs and challenges faced by practitioners and patients and to amplify the positive impact of community-based pharmacy teams. Dr. Bacci practiced in community pharmacy for 10 years in chain and independent settings and is a Board Certified Ambulatory Care Pharmacist (BCACP). She remains highly engaged in practice as a member of the Washington State Pharmacy Association (WSPA) Board of Directors, a Network Facilitator for CPESN WA, and as a leader in the nationwide Academia-Community Transformation (ACT) Pharmacy Collaborative, supporting community pharmacy practice transformation efforts. Her work has been recognized with awards such as the 2021 Albert B. Prescott Pharmacy Leadership Award and the 2019 Washington State Distinguished Young Pharmacist of the Year Award.

Research topics

• Political Science
• Medicine
• Nursing
• Medical education
• Family medicine
• Sociology
• Computer Science
• Psychiatry
• Public relations
• Business
• Management
• Psychology
• Knowledge management
• Economics
• Internal medicine
• Physical therapy
• Immunology

Selected publications

• Pharmacy access and shingles vaccinations in the US: a propensity score matching analysis

  Vaccine · 2026-01-30

  article
  PublisherDOI

• Community pharmacy practice transformation: Evaluating sustainability of patient care services

  Journal of the American Pharmacists Association · 2026-03-23

  article
  PublisherDOI

• Improving pharmacy-based HPV vaccine delivery through communication training: Findings from a pilot feasibility study

  Journal of the American Pharmacists Association · 2026-03-20

  articleOpen access
  PublisherOA PDFDOI

• Acceptability, Appropriateness, and Feasibility of Administering Long-Acting Injectable Antipsychotics in Community Pharmacies

  Psychiatric Services · 2026-02-05

  articleSenior author

  OBJECTIVE: Long-acting injectable antipsychotics (LAIAs) are evidence-based treatments for schizophrenia with demonstrated improved adherence and health outcomes relative to oral antipsychotics. Despite their benefits, LAIAs remain underprescribed. Administering LAIAs in community pharmacies could improve uptake, but the feasibility of integrating new services in this setting is often disregarded. The authors aimed to evaluate the feasibility, acceptability, and appropriateness of administering LAIAs in community pharmacies in Washington State. METHODS: Community pharmacy staff and psychiatric clinicians in Washington State were recruited, via both purposive and snowball sampling, through the Washington State Pharmacy Association and University of Washington's Department of Psychiatry and Behavioral Sciences. Participants' perceptions were assessed via a cross-sectional survey that included a questionnaire completed by pharmacy staff and three measures completed by psychiatric clinicians. For all outcomes, higher scores indicated more favorable responses. The data were analyzed with descriptive statistics. Simple linear regression models and comparisons across respondent groups were performed where possible. RESULTS: Ninety-three respondents initiated a survey; 89 met eligibility criteria. The pharmacists' mean scores were 4.98 (out of 6) for acceptability, 4.34 (out of 6) for feasibility, and 3.91 (out of 5) for appropriateness; the pharmacy technicians' mean respective scores were 5.43, 4.28, and 3.90. The clinicians' scores (measured on a 5-point Likert scale) were 4.20 for acceptability, 4.01 for appropriateness, and 3.92 for feasibility. CONCLUSIONS: The respondents surveyed viewed LAIA administration in community pharmacies as acceptable, appropriate, and feasible, indicating compatibility with early implementation efforts to support service development and expansion.

  PublisherDOI

• Provision of Mental and Behavioral Health Supports and Services by Pharmacists in Washington State

  Community Mental Health Journal · 2025-01-03 · 2 citations

  articleSenior author
  PublisherDOI

• Pediatric vaccination in pharmacies is not associated with delayed well-child visits among commercially insured children

  Health Affairs Scholar · 2025-02-01 · 1 citations

  articleOpen accessSenior author

  Pediatric vaccination rates in the United States lag national goals. Policies that expand pharmacy-based vaccinations among children could help improve vaccination rates. Opponents argue, however, that such policies will result in delayed or missed well-child visits as most children receive routine vaccinations in primary care settings. We evaluated the likelihood of having a timely well-child visit following a routine vaccination in pharmacies and primary care settings among children aged 4-17 years. We conducted a retrospective cohort analysis with commercial claims data from 2016-2019, using conditional logistic regression models. A timely well-child visit was defined as one within 12 months after a preceding well-child visit for primary analysis and 15 months for secondary analysis. Approximately 95% of the sample consisted of children with influenza among their index vaccine(s). The odds of having a timely well-child visit were similar between children who received vaccines in pharmacies and those who received them in primary care settings. Findings suggest that guardians or parents who choose pharmacy-based pediatric vaccinations for their commercially insured children do not forgo well-child visits and may actually be more likely to obtain a timely well-child visit. Extending pharmacy-based vaccinations to patients of all ages can help improve pediatric vaccination rates.

  PublisherOA PDFDOI

• Building Implementation Science Capacity in Academic Pharmacy: Report of the 2020–2021 AACP Research and Graduate Affairs Committee

  American Journal of Pharmaceutical Education · 2025-07-16

  articleOpen access

  The 2020-2021 American Association of Colleges of Pharmacy (AACP) Research and Graduate Affairs Committee (RGAC) continued the work begun by the 2019-2020 RGAC to increase awareness of and capacity for implementation research to advance practice transformation in academic pharmacy. AACP President Anne Lin charged the RGAC with developing resources and programs for training faculty and graduate students in implementation science. The committee was further charged with developing a mechanism to pair pharmacy faculty and implementation experts on practice advancement projects. In its work, the committee focused on generating near-term opportunities for pharmacy practice faculty to pursue projects while developing programs that would support ongoing career development and future implementation practice and research by pharmacy faculty and trainees. To support training, the RGAC developed a competency framework for graduate education that builds on the 6 domains of graduate education in pharmaceutical sciences put forward by the 2016-2017 RGAC. The new, specialized framework identifies and organizes those competencies that should be cultivated to successfully pursue implementation research in pharmacy, with utility beyond graduate education. The identified competencies could act as the base for pharmacy-specific implementation science training materials suitable for faculty development. The committee proposes a faculty development program that leverages the framework and existing implementation science training resources offered by federal agencies and universities to provide facilitated learning opportunities and peer support for faculty who wish to pursue implementation research. The committee considered multiple approaches AACP could take to promote collaboration between pharmacy faculty and implementation experts. While recognizing the importance of individual development support for pharmacy faculty, the committee felt that a focus on supporting interdisciplinary teams that span practice and research and engage faculty, trainees and preceptors would have the greatest impact on enabling practice advancement projects in the near-term while increasing capacity in the long-term. The committee envisions a program in which AACP creates opportunities for pharmacy faculty and implementation experts to come together with the purpose of matching researchers and projects. AACP support for these collaborations should begin prior to any such matching event, for example, by helping pharmacy faculty articulate the scope and value of their proposed practice advancement projects, and extend beyond the initial match to include assisting nascent collaborations as they seek to establish connections and secure institutional and external backing. The RGAC made specific recommendations to AACP about how the framework and proposed programs could be used to further develop pharmacy faculty and graduate students as researchers while advancing the goal of sustainable transformation of pharmacy practice. A key recommendation is that AACP cultivate an inclusive community of interest in implementation science in pharmacy that will promote adoption of the framework, act as facilitators and coaches for training programs and assist in planning and supporting collaborative research projects.

  PublisherDOI

• Developing Community Pharmacist Prescribing Models to Expand Access to Medications for Opioid Use Disorder

  Journal of Addiction Medicine · 2025-09-12

  article1st authorCorresponding

  OBJECTIVES: The Mainstreaming Addiction Treatment Act removed the separate registration requirement to prescribe scheduled medications for maintenance or detoxification treatment, creating an opportunity to utilize community pharmacists' expertise and accessibility to expand access to medications for opioid use disorder (MOUD). This study aimed to develop pharmacist prescribing models of care within community pharmacies. METHODS: Data were collected via interviews with community pharmacists and pharmacy technicians, treatment providers, and people with lived experience in Washington State from January to May 2024. Interviews were analyzed using a rapid content analysis approach guided by the Practice, Robust Implementation and Sustainability Model and existing evidence-based models of care for MOUD in primary care settings. The research team utilized the themes to develop models of care with input from an interdisciplinary advisory panel. RESULTS: Thirty-one interviews were conducted with 9 community pharmacy staff, 11 treatment providers, and 11 people with lived experience. In total, 21 themes were identified, including 8 themes regarding intervention characteristics, 5 regarding recipients, 5 regarding implementation and sustainability infrastructure, and 3 regarding external environment. Within intervention characteristics, 3 themes were identified regarding medication therapy, 3 regarding education, 1 regarding coordination of care, and 1 regarding psychosocial services. Two models of care were developed: one for MOUD initiation and another for maintenance or ongoing treatment. CONCLUSIONS: This study resulted in the development of models of care for MOUD initiation and maintenance at community pharmacies. Future research is needed to evaluate the effectiveness of these models of care.

  PublisherDOI

• Perceptions and practices of long-acting injectable antipsychotic administration in community pharmacies within Washington State: A qualitative implementation science study

  Journal of the American Pharmacists Association · 2025-11-03 · 1 citations

  article
  PublisherDOI

• Implementing payer partnerships for patient care programs within clinically integrated networks of community pharmacies: A qualitative study

  Journal of the American Pharmacists Association · 2025-10-01

  articleOpen accessSenior author
  PublisherOA PDFDOI

Frequent coauthors

• Melissa Somma McGivney

  University of Pittsburgh

  30 shared

• Maria Osborne

  17 shared

• Sarah Krahe Dombrowski

  17 shared

• Patricia Klatt

  St. Margaret Memorial Hospital

  17 shared

• Gregory Castelli

  University of Pittsburgh

  17 shared

• Aaron Difilippo

  University of Washington

  16 shared

• Peggy Soule Odegard

  15 shared

• Andy Stergachis

  University of Washington

  13 shared

Education

• Other

  University of Pittsburgh School of Pharmacy

• Other

  University of Pittsburgh School of Public Health

Awards & honors

• 2021 Albert B. Prescott Pharmacy Leadership Award
• 2019 Washington State Distinguished Young Pharmacist of the…
• 2018 NAIIS “Immunization Neighborhood” Adult Immunization Ch…
• 2018 American Pharmacist Association Immunization Champion A…